Finance

Benchmark Genetics reports drop in quarterly profit, revenue

The aquaculture genetics company said a strategic review, including a potential sale of the company, is ongoing.

"Our Advanced Nutrition business remains resilient to the continuing soft conditions in the shrimp markets and is well positioned for market recovery," Benchmark Genetics CEO Trond Williksen said.
"Our Advanced Nutrition business remains resilient to the continuing soft conditions in the shrimp markets and is well positioned for market recovery," Benchmark Genetics CEO Trond Williksen said.Photo: Anders Furuset
Correspondent
Published 22 August 2024, 09:24Updated 22 August 2024, 09:24
BenchmarkTrond WilliksenGeneticsMergers & AcquisitionsNorway